-
Comparative Efficacy of Iptacopan Monotherapy vs. Danicopan Add-on to C5i in Paroxysmal Nocturnal Hemoglobinuria (PNH) Results From an Indirect Treatment Comparison (ITC)
Sep 9, 2025, 16:22 PM -
Have Delays in Vaccine Market Access Improved in Europe and the US Over the Last Decade?
Sep 9, 2025, 16:22 PM -
Budget Impact of the VELYS™ Robotic-Assisted Solution Compared to Manual Procedure in Patients Undergoing Primary Total Knee Arthroplasty in France
Sep 9, 2025, 16:22 PM -
Grounded Theory Study to Assess Barriers and Reasons for Insufficient Compliance With Valproate Risk Minimization Measures: Example of a Qualitative Method Aligned With the Recommendations of the GVP Module XVI, Addendum II
Sep 9, 2025, 16:22 PM -
From Anxiety to Hope: Understanding the Adoption of AI Counseling Tools for Anxiety Management
Sep 9, 2025, 16:22 PM -
Incidence and Prevalence of Primary Biliary Cholangitis (PBC) and Cholestatic Pruritus (CP) in Germany: Results From a Statutory Health Insurance (SHI) Claims Analysis
Sep 9, 2025, 16:22 PM -
Methodological Insights From Recent PBAC Recommendations to Support Biosimilar Reimbursement in Australia
Sep 9, 2025, 16:22 PM -
Impact of Mucus Plugs on the Health Economic Burden in Chronic Obstructive Pulmonary Disease (COPD) Patients
Sep 9, 2025, 16:22 PM -
Role of Real-World Evidence (RWE) in Pricing and Reimbursement Decisions for Rare Disease in Health Technology Assessment (HTA) Submissions Across EU4 + UK
Sep 9, 2025, 16:22 PM -
Systematic Literature Review and Bayesian Network Meta-Analysis of Sugemalimab Plus Chemotherapy vs. Other First-Line Treatments for Metastatic Non-Small Cell Lung Cancer Without Sensitizing eGFR, ALK, ROS1, or RET Alterations
Sep 9, 2025, 16:22 PM -
Identification of Real-World Data to Study HAE Unmet Need: A Targeted Literature Review
Sep 9, 2025, 16:22 PM -
The Cost-Effectiveness of Targeted-Release Form (TRF)-Budesonide for the Treatment of Adult Population With Immunoglobulin A Nephropathy (IgAN) in Greece
Sep 9, 2025, 16:22 PM -
Real-life-Persistence to Antifibrotic Treatments in the French Population
Sep 9, 2025, 16:22 PM -
Relevance of Quality Indicators for Supporting Patients’ Choice of Hospitals: An Online Survey
Sep 9, 2025, 16:22 PM -
Modeling the Healthcare Burden of Oral Corticosteroid Use in Mexico
Sep 9, 2025, 16:22 PM -
Economic Evaluation of Dinutuximab Beta in the Maintenance Therapy of High-Risk Neuroblastoma in Brazil
Sep 9, 2025, 16:22 PM -
Efficacy of Pregabalin and High-Concentration (179 mg) Capsaicin Patch in Peripheral Neuropathic Pain: A Review of Studies ≥ 26 Weeks' Duration
Sep 9, 2025, 16:22 PM -
Comparative Efficacy and Safety of Delgocitinib, Alitretinoin, and PUVA in Patients With Moderate-to-Severe Chronic Hand Eczema: A Network Meta-Analysis
Sep 9, 2025, 16:22 PM -
Similarities and Differences Between the National Institute for Health and Care Excellence (NICE) and European Union Joint Clinical Assessment (EU JCA) Clinical Systematic Literature Review Requirements
Sep 9, 2025, 16:22 PM -
Hospital Burden of Pulmonary Arterial Hypertension in France: A Real-World Study Using the French Hospitalization Database (PMSI)
Sep 9, 2025, 16:22 PM
